Jayaram, H N

Conversion of 2-beta-D-ribofuranosylselenazole-4-carboxamide to an analogue of NAD with potent IMP dehydrogenase-inhibitory properties. [electronic resource] - Biochemical pharmacology Sep 1983 - 2633-6 p. digital

Publication Type: Journal Article

0006-2952

10.1016/0006-2952(83)90038-2 doi


Animals
Gas Chromatography-Mass Spectrometry
IMP Dehydrogenase--antagonists & inhibitors
Ketone Oxidoreductases--antagonists & inhibitors
Leukemia P388--drug therapy
Leukemia, Experimental--drug therapy
Mice
NAD--analogs & derivatives
Organoselenium Compounds
Ribavirin--analogs & derivatives
Ribonucleosides--chemical synthesis
Selenium--chemical synthesis